Release Date: 30/01/15 13:49 Summary: Quarterly Activities Report and Appendix 5B Price Sensitive: Yes Download Document 205.36KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling